
Bilateral salpingectomy should be considered in patients who are already undergoing hysterectomy for other indications.

Bilateral salpingectomy should be considered in patients who are already undergoing hysterectomy for other indications.

How would a male gynecologist begin to know anything about a woman's orgasm? Easy. In my pre-operative counseling for hysterectomy I discuss sexuality, orgasm, and hysterectomy. And I tell my patient that a year later I'm going to ask her about it. But this is not a controlled scientific study, so before telling you what I am hearing, let's look at some real data.

A new study looks at whether ovary-sparing hysterectomies can lead to early menopause. Plus: Does betamethasone reduce respiratory complications in preterm infants? Also, the impact of the vaginal microbiome on preterm birth.

When a jury sees a diagnosis of HIE, it is very difficult to show them that no hypoxia occurred in labor, even in the face of normal cord blood gases.

A look at the impact of prehypertension on the risk of stillbirth. And, the CDC issues guidance on alcohol consumption in women of childbearing years. Plus: Does the type of hysterectomy alter endometrial cancer survival?

Dispatches from the 44th AAGL Global Congress looks at the incidence of occult sarcoma and a look at what patient characteristics may lead to using morcellation during hysterectomy.

The results of a new study on Vitamin D and pregnancy outcome. Plus, Is foam the future of nonsurgical female sterilization? And: Choosing a GnRH dose for ovarian stimulation

A new study examines the risk:benefit of the Essure device. And, does anti-osteoporosis medication in the wake of a fragility fracture reduce the risk of a future fracture? Plus: What role do high maternal blood glucose levels play in her child's future cardiovascular health?

A study tabulates the direct and indirect costs.

The FBI is investigating how much the manufacturer knew about the safety of the design. Plus, how does the clotting profile of new oral contraceptives compare to earlier formulations and a look at the impact of the PALB2 mutation on breast cancer prognosis.

A patient sues after a hysterectomy is performed even after a finding of no cancer.

Two experts take sides on the clinical merits of performing bilateral salpingectomy alone versus removing the tubes in BRCA mutation carriers.

More information on the risks of morcellation when treating fibroids; a look at the price tag associated with post-fracture use of bisphosphonates; and research on the developmental impact of a variety of air pollution.

In the latest volley in the ongoing controversy regarding the safety of some forms of hysterectomy, the country’s largest insurer will soon begin requiring prior authorization for many of the procedures. The action, taken by UnitedHealthCare, takes effect April 6, 2015 and does not apply to outpatient vaginal surgeries.

Readers comment on MOC, ureteral injury, nonimmune hydrops fetalis

Among BRCA mutation carriers, risk-reducing bilateral salpingo-oophorectomy (RRSO) results in an 80% reduction in risk of ovarian cancer and a 50% reduction in risk of breast cancer if the surgery is performed before the onset of menopause.

Six months after a tubal ligation, a woman became pregnant. She gave birth by cesarean to a child who was diagnosed with sickle cell disease.

A reader takes issue with the authors' assertion that risk of ureteral injury is higher for vaginal hysterectomy.

On July 29, 2010, a 46-year-old obese primarily Spanish-speaking patient was admitted to a hospital by her private ob/gyn Dr. A for a total laparoscopic hysterectomy (TLH) and/or laparoscopically assisted vaginal hysterectomy (LAVH) that day.

A California woman with a history of 2 premature deliveries and a single miscarriage became pregnant in 2004. A few days after the pregnancy was confirmed, she was seen by a physician at a military base in connection with an application to accompany her husband overseas. The application was approved and the patient went to Spain, where she delivered at 31 weeks’ gestation in 2005.

On November 25, the Food and Drug Agency (FDA) issued a warning against the use of laparoscopic power morcellators in the management of many women undergoing hysterectomy or myomectomy.

AAGL attendees are normally reserved, but on Wednesday they got on their feet to give an ovation to the doctor who engineered the first pregnancy in a woman with a transplanted uterus.

An analysis of data from nearly 90,000 women who underwent adnexal surgery over a 3-year period shows that robotically assisted procedures were associated with substantially higher costs and increases in intraoperative complications.

Javier F Magrina, MD, demonstates the prevention of ureteral injury while performing an endoscopic hysterectomy.

When a jury sees a big corporation in the defendant’s chair, it can have an effect, although it is never a jury’s job to “punish” a corporation.